Ferric derisomaltose in hospitalised and ambulatory patients with heart failure-insights from the IRONMAN trial

Back

HFA Premium Access

Ferric derisomaltose in hospitalised and ambulatory patients with heart failure-insights from the IRONMAN trial

Session: Chronic heart failure - pathophysiology and mechanisms 11

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Doctor M. Lee (Glasgow, GB)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Doctor Matthew M Y Lee

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

6 more presentations in this session

Clinical management strategies of cardiologists in heart failure with reduced ejection fraction

Speaker: Doctor T. Kivrak (Elazig, TR)

Prevalence, characteristics, and phenotype associated with tachycardiomyopathy in a cohort of patients first hospitalized for heart failure with reduced ejection fraction

Speaker: Mr P. de la Fuente Lopez (A Coruna, ES)

An intensive nurse-led telemedicine program is effective in achieving optimized up-titration of prognostic drugs in heart failure with reduced ejection fraction patients

Speaker: Mrs M. Vicente Elcano (Barcelona, ES)

Effect of initiation of sacubitril/valsartan on 24 hours blood pressure in patients with heart failure with reduced ejection fraction

Speaker: Mr M. Pavelko (Lutsk, UA)

TAPSE is a small but big important detail in candidates for heart transplantation

Speaker: Professor R. Acar (Istanbul, TR)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 11

Speakers: Doctor M. Lee, Doctor T. Kivrak, Mr P. de la Fuente Lopez, Mrs M. Vicente Elcano, Mr M. Pavelko...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources